top of page

The voice of Colville and northeastern Washington since 1896

|

September 15, 2026

COLVILLE, WA

58°F

Chance Light Rain

About
Contact
Place an Ad
Submissions
Freelance Opportunities
Join Our Team

LETTERS TO THE EDITOR

Recent Quotes

My Watchlist

Indicators

Dow Jones Industrial Average

Markets:

Overview

News

Currencies

International

Treasuries

NeuroSense Therapeutics Ltd. - Ordinary Shares (NQ:NRSN)

1.395 -0.025 (-1.76%)

Delayed Quote Updated: 4:00 PM EST, Nov 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NeuroSense Therapeutics Ltd. - Ordinary Shares

< Previous 1 2 3 4 Next >

Aspen Aerogels And 28 Stocks Moving Premarket ↗

June 30, 2022

Gainers

Via Benzinga

Global Pancreatic Cancer Therapeutics & Diagnostics Market Expected To Reach $5.6 Billion By 2027

June 28, 2022

Palm Beach, FL – June 28, 2022 – FinancialNewsMedia.com News Commentary – Pancreatic cancer therapeutics and diagnostics involve medical procedures used to diagnose pancreatic cancer and subsequent...

Via FinancialNewsMedia

NeuroSense Shares Surge Over 400% As FDA Clears Initiating Pharmacokinetic Study Of PrimeC ↗

March 21, 2022

Via Benzinga

Why Is Kezar Life Sciences Surging By 78%? 25 Stocks Moving In Tuesday's Pre-Market Session ↗

June 28, 2022

Gainers Kezar Life Sciences, Inc. (NASDAQ: KZR) rose 78% to $10.29 in pre-market trading after the company reported positive topline results from the MISSION Phase 2 clinical trial evaluating...

Via Benzinga

This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday ↗

June 28, 2022

Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.

Via Benzinga

Why NeuroSense Therapeutics Stock Is Soaring Today ↗

June 27, 2022

NeuroSense Therapeutics Ltd (NASDAQ: NRSN) shares are up more than 60% after the company reported results from a stage III ALS Biomarker study evaluating PrimeC.

Via Benzinga

Crude Oil Surges 2.5%; Evofem Biosciences Shares Jump ↗

June 27, 2022

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping over 50 points on Monday.

Via Benzinga

Stocks Struggling For Direction In 'Meandering' Market ↗

June 27, 2022

Stocks are struggling for direction midday, as the major benchmarks attempt to keep up last week's momentum.

Via Talk Markets

NeuroSense Therapeutics (NRSN) Stock Pops on Positive ALS Study Results ↗

June 27, 2022

NRSN stock is getting plenty of attention today and a bid to the tune of more than 70% in the wake of positive clinical results.

Via InvestorPlace

Nasdaq Drops 75 Points; Acutus Medical Shares Spike Higher ↗

June 27, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 75 points on Monday.

Via Benzinga

Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session ↗

June 27, 2022

Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade.

Via Benzinga

12 Stocks Halted On A Circuit Breaker This Week ↗

March 25, 2022

A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It is a measure put in place to help restore, and...

Via Benzinga

32 Stocks Moving in Wednesday's Pre-Market Session ↗

March 23, 2022

Gainers Zentek Ltd. (NASDAQ: ZTEK) rose 180.5% to $7.63 in pre-market trading after declining around 5% on Tuesday. Creative Realities Inc (NASDAQ: CREX) shares rose 52.6% to $1....

Via Benzinga

53 Biggest Movers From Yesterday ↗

April 08, 2022

Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 64.4% to close at $1.41 on Thursday. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail...

Via Benzinga

43 Stocks Moving In Tuesday's Mid-Day Session ↗

March 22, 2022

Gainers Forge Global Holdings Inc. (NYSE: FRGE) shares jumped 67.7% to $16.95. True Global Ventures’ portfolio company Forge Global Holdings completed its business...

Via Benzinga

53 Biggest Movers From Yesterday ↗

March 30, 2022

Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA (NASDAQ: SNY) and IGM Biosciences signed an exclusive worldwide...

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; Nasdaq Surges Over 1% ↗

March 22, 2022

U.S. stocks opened on a strong note this morning, with the Nasdaq Composite adding more than 1% on Tuesday. Following the market opening Tuesday, the Dow traded up 0.84% to 34,842...

Via Benzinga

Why Is NeuroSense Therapeutics (NRSN) Stock Up 300% Today? ↗

March 21, 2022

A thumbs up from the FDA has NRSN stock surging. Here's what this victory means for NeuroSense and for investors.

Via InvestorPlace

58 Biggest Movers From Yesterday ↗

March 24, 2022

Gainers Allego N.V. (NYSE: ALLG) shares surged 114.1% to close at $17.73 on Wednesday after the company announced the completion of its merger agreement with Spartan Acquisition...

Via Benzinga

Mid-Afternoon Market Update: Dow Tumbles 300 Points; Vallon Pharmaceuticals Shares Plunge ↗

March 21, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling more than 300 points on Monday. The Dow traded down 0.95% to 34,424.62 while the NASDAQ fell 1.05%...

Via Benzinga

75 Biggest Movers From Yesterday ↗

March 22, 2022

Gainers NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) shares jumped 299.4% to close at $6.23 on Monday as the company received clearance from the FDA to initiate a pharmacokinetic...

Via Benzinga

Mid-Day Market Update: Nasdaq Drops 100 Points; NeuroSense Therapeutics Shares Spike Higher ↗

March 21, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq dropping around 100 points on Monday. The Dow traded down 0.78% to 34,482.95 while the NASDAQ fell 0.73% to 13,792...

Via Benzinga

46 Stocks Moving In Monday's Mid-Day Session ↗

March 21, 2022

Gainers NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) climbed 369% to $7.32 as the company received clearance from the FDA to initiate a pharmacokinetic study of PrimeC in...

Via Benzinga

Why NeuroSense Shares Are Soaring Today ↗

March 21, 2022

NeuroSense Therapeutics Ltd (NASDAQ: NRSN) shares are soaring Monday after the company announced it received U.S. Food and Drug Administration clearance to...

Via Benzinga

27 Stocks Moving in Monday's Pre-Market Session ↗

March 01, 2022

Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 123.4% to $0.76 in pre-market trading after jumping 36% on Monday. American Rebel Holdings, Inc. (NASDAQ: AREB) rose 28.6...

Via Benzinga

76 Biggest Movers From Yesterday ↗

March 08, 2022

Gainers Houston American Energy Corp. (NYSE: HUSA) surged 494.7% to close at $11.30 on Monday amid continued momentum and an increase in the price of oil. Imperial Petroleum Inc...

Via Benzinga

42 Stocks Moving In Monday's Mid-Day Session ↗

February 28, 2022

Gainers Mullen Automotive, Inc. (NASDAQ: MULN) jumped 74.4% to $1.20 after the company reported progress on solid-state polymer battery pack development. Renewable Energy Group...

Via Benzinga

80 Biggest Movers From Yesterday ↗

March 02, 2022

Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) jumped 78.5% to close at $0.6066 on Tuesday after jumping 36% on Monday. CTI BioPharma Corp. (NASDAQ: CTIC) surged 63...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

February 28, 2022

We've got another busy week of trading ahead of us so let's start it off with the biggest pre-market stock movers for Monday!

Via InvestorPlace

67 Biggest Movers From Yesterday ↗

March 01, 2022

Gainers Mullen Automotive, Inc. (NASDAQ: MULN) climbed 145.6% to close at $1.69 on Monday after the company reported progress on solid-state polymer battery pack...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Local News
Government
Business
Sports
Arts & Entertainment
Farm & Ranch
Great Outdoors
Profiles

Out of the Past
Letters to the Editor
Classifieds
Announcements
Events Calendar
Obituaries
Commissioner Agendas
Superior Court Dockets

Home

About

Contact

Advertising

Legal Notices

Terms of Use

Privacy Policy

Accessibility

Submissions

Place an Ad

Submit an Event

News Tips

Corrections

Letters to the Editor

Freelance Opportunities

Home Delivery

Join our Team

Statesman-Examiner

220 S. Main St.
Colville, WA 99114

Hours: Mon.-Fri., 8 a.m.-5 p.m.

509-684-4567
editor@statesmanexaminer.com

PHOTO GALLERY

Website Designed by Amber S. King – Creative Design

Home
About
Contact
Submissions

About
Contact
Place an Ad
Submissions
Freelance Opportunities
Join Our Team

bottom of page